Improved outcomes with "upstream" use of glycoprotein IIb/IIIa inhibition prior to early percutaneous coronary intervention after admission for non-ST-segment elevation acute myocardial infarction

被引：0
|
作者：
Greenbaum, AB
Kleiman, NS
Berger, PB
Cohen, DJ
Cannons, CP
Brindis, R
Li, Y
Roe, MT
Harrington, RA
Peterson, E
Gibler, WB
Ohman, EM
机构：
[1] Henry Ford Heart & Vasc Inst, Detroit, MI USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Mayo Clin, Rochester, MN USA
[4] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[5] Brigham & Womens Hosp, Boston, MA 02115 USA
[6] Kaiser Permanente Hlth Syst, San Francisco, CA USA
[7] Duke Clin Res Inst, Durham, NC USA
[8] Univ Cincinnati, Sch Med, Cincinnati, OH USA
[9] Univ N Carolina, Sch Med, Chapel Hill, NC USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 92卷 / 6A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72L / 72L
页数：1
相关论文
共 50 条
  • [31] Comparison of the cost in percutaneous coronary intervention between ST-segment elevation myocardial infarction vs. non-ST-segment elevation myocardial infarction
    Tsukasa Murakami
    Kenichi Sakakura
    Yousuke Taniguchi
    Kei Yamamoto
    Takunori Tsukui
    Masaru Seguchi
    Hiroyuki Jinnouchi
    Hiroshi Wada
    Hideo Fujita
    Cardiovascular Intervention and Therapeutics, 2022, 37 : 293 - 303
  • [32] Comparison of the cost in percutaneous coronary intervention between ST-segment elevation myocardial infarction vs. non-ST-segment elevation myocardial infarction
    Murakami, Tsukasa
    Sakakura, Kenichi
    Taniguchi, Yousuke
    Yamamoto, Kei
    Tsukui, Takunori
    Seguchi, Masaru
    Jinnouchi, Hiroyuki
    Wada, Hiroshi
    Fujita, Hideo
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2022, 37 (02) : 293 - 303
  • [33] Percutaneous Intervention for Non-ST-Segment Elevation Myocardial Infarction Within the Therapeutic Time Window for Acute Myocardial Infarction
    Jolobe, Oscar M. P.
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (10) : 951 - 952
  • [34] Non-ST-segment Elevation Myocardial Infarction in a Patient With Essential Thrombocythemia Treated With Glycoprotein IIb/IIIa Inhibitor: A Case Report
    Zhang, Zhiyong
    Wan, Xinhong
    Liu, Yuanyuan
    Lin, Xiangmin
    Ni, Zhuhua
    Yang, Xinchun
    Zhang, Lin
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2011, 17 (05) : 532 - 534
  • [35] Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: Appropriate interpretation of the guidelines
    Antman, EM
    AMERICAN HEART JOURNAL, 2003, 146 (04)
  • [36] Early use of glycoprotein IIb/IIIa-receptor inhibitors in non-ST-segment-elevation acute coronary syndromes
    Marsh, JD
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (21) : S15 - S26
  • [37] ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction
    Hishikari, Keiichi
    Kakuta, Tsunekazu
    Lee, Tetsumin
    Murai, Tadashi
    Yonetsu, Taishi
    Isobe, Mitsuaki
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 87 (04) : E113 - E121
  • [38] Glycoprotein IIb/IIIa inhibitors: Therapeutic applications in acute ST-segment elevation myocardial infarction
    Campbell, KR
    Cantor, W
    Sketch, M
    Ohman, EM
    AMERICAN HEART JOURNAL, 2000, 140 (06) : S115 - S124
  • [39] Use of coronary revascularization in patients with unstable and non-ST-segment elevation acute myocardial infarction
    Popma, JJ
    Suk, J
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (8A): : 25K - 29K
  • [40] Glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST segment elevation myocardial infarction
    Cannon, CP
    CORONARY ARTERY DISEASE, 1999, 10 (08) : 561 - 566
12345